GENE ONLINE|News &
Opinion
Blog

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless

WRITTEN BY Joy Lin

Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
Novavax Begins Phase 2 For COVID-19/Influenza Combination And Stand-Alone Flu Shots
2023-01-03
Pfizer’s Hemophilia B Gene Therapy Meets Phase 3 Endpoints
2022-12-30
TG Notches FDA Victory For CD20 Antibody For Multiple Sclerosis
2022-12-29
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
Antengene To Pair CD73 Inhibitor With Merck’s Keytruda In Clinical Collaboration
2022-12-27
Immutep Expands Patient Population For LAG-3 Candidate After FDA Meeting
2022-12-26
Pfizer Begins Phase 2 Of Diabetes Drug, Triggering $10 Million Milestone To Sosei Heptares
2022-12-22
Kite Buys Tmunity To Chase Next-Generation CAR T-Cell Therapies
2022-12-21
Gilead, Arcus’ Anti-TIGIT Combinations Show Survival Advantage Over Anti-PD1 Monotherapy In Phase 2 Trial
2022-12-20
Biogen To Receive Potential Royalties For Anti-CD20 Bispecific From Genentech
2022-12-20
Novavax Offers Up $125 Million Of Stock For COVID-19 Vaccine Launch
2022-12-20
Astellas’ Zolbetuximab Meets Phase 3 Endpoints In Gastric And GEJ Cancers
2022-12-16
LG Chem Lands Innovent As China Partner For Gout Candidate
2022-12-15
Mirati Wins FDA Accelerated Approval For Lung Cancer Mutation
2022-12-14
1 … 3 4 5 6 7 … 25
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top